The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas
- PMID: 24134947
- PMCID: PMC4391706
- DOI: 10.1016/j.oraloncology.2013.09.008
The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas
Abstract
Human papillomavirus (HPV) is etiologically responsible for a distinct subset of head and neck squamous cell cancers (HNSCCs). HPV-positive HNSCCs (HPV-HNSCCs) most commonly arise from the oropharynx and are responsible for the increasing incidence of oropharyngeal SCC (OSCC) in the United States (US) and abroad. HPV-positive OSCC (HPV-OSCC) has a unique demographic and risk factor profile and tumor biology. HPV-OSCC patients tend to be white, younger, and have a higher cumulative exposure to sexual behaviors as compared with HPV-negative OSCC patients. HPV-positive tumor status also significantly improves survival, and is indeed the single strongest prognostic factor for OSCC. The mechanisms that underlie the improved prognosis conferred by HPV-positive disease are unknown. The purpose of this review is to describe the clinical impact of HPV status in HNSCC, particularly in OSCC, both in terms of the unique clinic-demographic profile and prognostic implications.
Keywords: HPV; Head and neck cancer; Oropharyngeal neoplasms; Prognosis; Risk factors.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Conflict of interest statement
None declared.
Similar articles
-
HPV Status Improves Classification of Head and Neck Gray Zone Cancers.J Dent Res. 2019 Jul;98(8):879-887. doi: 10.1177/0022034519853771. J Dent Res. 2019. PMID: 31282843
-
TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.Cancer. 2017 May 15;123(10):1778-1790. doi: 10.1002/cncr.30570. Epub 2017 Mar 13. Cancer. 2017. PMID: 28295222 Free PMC article.
-
Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.J Natl Cancer Inst. 2008 Mar 19;100(6):407-20. doi: 10.1093/jnci/djn025. Epub 2008 Mar 11. J Natl Cancer Inst. 2008. PMID: 18334711
-
The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: implications for dentistry.J Am Dent Assoc. 2011 Aug;142(8):915-24. doi: 10.14219/jada.archive.2011.0298. J Am Dent Assoc. 2011. PMID: 21804058 Review.
-
Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.Semin Radiat Oncol. 2012 Apr;22(2):128-42. doi: 10.1016/j.semradonc.2011.12.004. Semin Radiat Oncol. 2012. PMID: 22385920 Review.
Cited by
-
Prevalence of Co-infection by Human Papillomavirus, Epstein- Barr Virus and Merkel Cell Polyomavirus in Iranian Oral Cavity Cancer and Pre-malignant Lesions.Int J Mol Cell Med. 2022;11(1):64-77. doi: 10.22088/IJMCM.BUMS.11.1.64. Epub 2022 Oct 3. Int J Mol Cell Med. 2022. PMID: 36397808 Free PMC article.
-
Screening for irradiation vasculopathy by intima-media thickness sonography in head and neck cancer patients.Eur Arch Otorhinolaryngol. 2021 Jun;278(6):2017-2026. doi: 10.1007/s00405-020-06301-3. Epub 2020 Sep 1. Eur Arch Otorhinolaryngol. 2021. PMID: 32870365 Free PMC article.
-
Knowledge of Oral Cancer among the Fourth and Fifth Year Dental Students.Acta Stomatol Croat. 2018 Dec;52(4):340-347. doi: 10.15644/asc52/4/8. Acta Stomatol Croat. 2018. PMID: 30666065 Free PMC article.
-
Oropharyngeal squamous cell carcinoma treatment: current standards and future directions.Curr Opin Oncol. 2014 May;26(3):252-8. doi: 10.1097/CCO.0000000000000072. Curr Opin Oncol. 2014. PMID: 24626127 Free PMC article. Review.
-
An Analysis and Comparison of Survival and Functional Outcomes in Oropharyngeal Squamous Cell Carcinoma Patients Treated with Concurrent Chemoradiation Therapy within City of Hope Cancer Center Sites.J Clin Med. 2020 Sep 24;9(10):3083. doi: 10.3390/jcm9103083. J Clin Med. 2020. PMID: 32987866 Free PMC article.
References
-
- Sikora AG, Toniolo P, DeLacure MD. The changing demographics of head and neck squamous cell carcinoma in the United States. Laryngoscope. 2004;114(11):1915–23. http://dx.doi.org/10.1097/01.mlg.0000147920.66486.bc. - DOI - PubMed
-
- Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck. 2012 [Epub 2012/01/24]. doi: http://dx.doi.org/10.1002/hed.22015. - DOI - PubMed
-
- Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–301. [Epub 2011/10/05]. doi: http://dx.doi.org/JCO.2011.36.4596[[pii] 10.1200/JCO.2011.36.4596. - PMC - PubMed
-
- Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the US population ages 20–44 years. Cancer. 2005;103(9):1843–9. http://dx.doi.org/10.1002/cncr.20998. - DOI - PubMed
-
- Colevas AD. Population-based evaluation of incidence trends in oropharyngeal cancer focusing on socioeconomic status, sex, and race/ethnicity. Head Neck. 2013 http://dx.doi.org/10.1002/hed.23253. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials